APA Citation

Ohba, S., & Hirose, Y. (2019). DRES-03. PARP INHIBITOR, INHIBITION OF HOMOLOGOUS RECOMBINATION, OR DIANHYDRODULCITOL CAN OVERCOME TEMOZOLOMIDE-RESISTANCE IN GLIOMA CELLS. Neuro Oncol.

Citação norma Chicago

Ohba, Shigeo, and Yuichi Hirose. "DRES-03. PARP INHIBITOR, INHIBITION OF HOMOLOGOUS RECOMBINATION, OR DIANHYDRODULCITOL CAN OVERCOME TEMOZOLOMIDE-RESISTANCE IN GLIOMA CELLS." Neuro Oncol 2019.

MLA Citation

Ohba, Shigeo, and Yuichi Hirose. "DRES-03. PARP INHIBITOR, INHIBITION OF HOMOLOGOUS RECOMBINATION, OR DIANHYDRODULCITOL CAN OVERCOME TEMOZOLOMIDE-RESISTANCE IN GLIOMA CELLS." Neuro Oncol 2019.

Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.